Earnings results for Encompass Health (NYSE:EHC)
Encompass Health Corporation is expected* to report earnings on 04/27/2021 after market close. The report will be for the fiscal Quarter ending Mar 2021. According to Zacks Investment Research, based on 6 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.8. The reported EPS for the same quarter last year was $0.87.
Encompass Health last issued its quarterly earnings data on January 26th, 2021. The reported $0.93 EPS for the quarter, beating analysts’ consensus estimates of $0.86 by $0.07. The firm earned $1.21 billion during the quarter, compared to analyst estimates of $1.21 billion. Encompass Health has generated $3.91 earnings per share over the last year and currently has a price-to-earnings ratio of 32.7.
Analyst Opinion on Encompass Health (NYSE:EHC)
5 Wall Street analysts have issued ratings and price targets for Encompass Health in the last 12 months. Their average twelve-month price target is $90.80, predicting that the stock has a possible upside of 4.10%. The high price target for EHC is $96.00 and the low price target for EHC is $86.00. There are currently 5 buy ratings for the stock, resulting in a consensus rating of “Buy.”
Encompass Health has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings. According to analysts’ consensus price target of $90.80, Encompass Health has a forecasted upside of 4.1% from its current price of $87.22. Encompass Health has only been the subject of 1 research reports in the past 90 days.
Dividend Strength: Encompass Health (NYSE:EHC)
Encompass Health has a dividend yield of 1.26%, which is in the bottom 25% of all stocks that pay dividends. Encompass Health has only been increasing its dividend for 1 years. The dividend payout ratio of Encompass Health is 28.64%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Encompass Health will have a dividend payout ratio of 29.32% next year. This indicates that Encompass Health will be able to sustain or increase its dividend.
Insiders buying/selling: Encompass Health (NYSE:EHC)
In the past three months, Encompass Health insiders have not sold or bought any company stock. Only 1.80% of the stock of Encompass Health is held by insiders. 89.92% of the stock of Encompass Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.
Earnings and Valuation of Encompass Health (NYSE:EHC
Earnings for Encompass Health are expected to grow by 34.98% in the coming year, from $2.83 to $3.82 per share. The P/E ratio of Encompass Health is 32.67, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.19. The P/E ratio of Encompass Health is 32.67, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 45.69. Encompass Health has a PEG Ratio of 9.32. PEG Ratios above 1 indicate that a company could be overvalued. Encompass Health has a P/B Ratio of 5.08. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.
More latest stories: here